Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2018

01-03-2018 | Case Report

Major and Minor Duodenal Papilla Neuroendocrine Tumors in Type 1 Neurofibromatosis: Case Report

Authors: M. R. Zandomeni, M. Chahdi Beltrame, M. de Santibañes, O. Mazza, J. Pekolj, E. de Santibañes, R. Sanchez Claria

Published in: Journal of Gastrointestinal Cancer | Issue 1/2018

Login to get access

Excerpt

Type 1 neurofibromatosis (NF1), or von Recklinghausen disease, is one of the most common autosomal-dominant disorders with an incidence of 1 in every 2500 to 3000 births. NF1 is caused by a germline mutation in NF1 tumor suppressor gene located on chromosome 17q11.2. The NF1 gene encodes neurofibromin, a cytoplasmic protein which plays a fundamental role in negative regulation of the Ras cellular proliferation pathway. Therefore, patients with NF1 are at higher risk of developing various tumors, such as neurofibromas, neurofibrosarcomas, stromal tumors, neuroendocrine tumors, and gliomas [13]. About 5–25 % of patients with NF1 have gastrointestinal manifestations such as neurofibromas, gastrointestinal stromal tumors (GISTs) of the small bowel, and periampullary neuroendocrine tumors (NETs); however, only 5 % of them have been reported as symptomatic [4, 5]. …
Literature
3.
go back to reference Spyk SL, Thomas N, Cooper DN, Upadhyaya M. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Human Genomics. 2011;5(6):623–90.CrossRefPubMedCentral Spyk SL, Thomas N, Cooper DN, Upadhyaya M. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Human Genomics. 2011;5(6):623–90.CrossRefPubMedCentral
4.
5.
go back to reference Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. International Journal of Clinical and Experimental Pathology. 2012;5(9):852–62.PubMedPubMedCentral Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations. International Journal of Clinical and Experimental Pathology. 2012;5(9):852–62.PubMedPubMedCentral
7.
go back to reference Albores-Saavedra J, Hart A, Chable-Montero F, Henson DE. Carcinoid and high grade neuroendocrine carcinoma of the ampulla of Vater – a comparative analysis of 139 cases from surveillance, epidemiology, and end results program – A population based study. Arch Pathol Lab Med. 2010;134:1692–96.PubMed Albores-Saavedra J, Hart A, Chable-Montero F, Henson DE. Carcinoid and high grade neuroendocrine carcinoma of the ampulla of Vater – a comparative analysis of 139 cases from surveillance, epidemiology, and end results program – A population based study. Arch Pathol Lab Med. 2010;134:1692–96.PubMed
8.
go back to reference Hartel M, Wente MN, Sido B, Friess H, Büchler MW. Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol. 2005;20:676–81.CrossRefPubMed Hartel M, Wente MN, Sido B, Friess H, Büchler MW. Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol. 2005;20:676–81.CrossRefPubMed
9.
go back to reference Relles D, Baek J, Witkiewicz A, et al. Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases. J Gastrointest Surg. 2010;14:1052–61. doi:10.1007/s11605-009-1123-0.CrossRefPubMed Relles D, Baek J, Witkiewicz A, et al. Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases. J Gastrointest Surg. 2010;14:1052–61. doi:10.​1007/​s11605-009-1123-0.CrossRefPubMed
10.
go back to reference Nikou GC, Toubanakis C, Moulakakis KG, Pavlatos S, Kosmidis C, Mallas E, et al. Carcinoid tumors of the duodenum and the ampulla of Vater: current diagnostic and therapeutic approach in a series of 8 patients. Case series Int J Surg. 2011;9:248–53.CrossRefPubMed Nikou GC, Toubanakis C, Moulakakis KG, Pavlatos S, Kosmidis C, Mallas E, et al. Carcinoid tumors of the duodenum and the ampulla of Vater: current diagnostic and therapeutic approach in a series of 8 patients. Case series Int J Surg. 2011;9:248–53.CrossRefPubMed
11.
go back to reference Dumitrascu T, Dima S, Herlea V, Tomulescu V, Ionescu M, Popescu I. Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis. Langenbeck’s Archives of Surgery. 2012;397(6):933–43.CrossRefPubMedPubMedCentral Dumitrascu T, Dima S, Herlea V, Tomulescu V, Ionescu M, Popescu I. Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis. Langenbeck’s Archives of Surgery. 2012;397(6):933–43.CrossRefPubMedPubMedCentral
14.
go back to reference Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, et al. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology. 2012;95:74–87. doi:10.1159/000335595.CrossRefPubMed Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, et al. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology. 2012;95:74–87. doi:10.​1159/​000335595.CrossRefPubMed
15.
go back to reference Randle RW, Ahmed S, Newman NA, et al. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study. Gastrointest Surg. 2014;18(2):354–62.CrossRef Randle RW, Ahmed S, Newman NA, et al. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study. Gastrointest Surg. 2014;18(2):354–62.CrossRef
16.
go back to reference Oller B, Haetta HH, Lorenzo-Zúñiga V, Julián JF, Moreno de Vega V, Fernández-Llamazares J, et al. Double somatostatinoma and double papillectomy in a patient with type 1 neurofibromatosis. Endoscopy. 2012;44:E344–5.CrossRefPubMed Oller B, Haetta HH, Lorenzo-Zúñiga V, Julián JF, Moreno de Vega V, Fernández-Llamazares J, et al. Double somatostatinoma and double papillectomy in a patient with type 1 neurofibromatosis. Endoscopy. 2012;44:E344–5.CrossRefPubMed
Metadata
Title
Major and Minor Duodenal Papilla Neuroendocrine Tumors in Type 1 Neurofibromatosis: Case Report
Authors
M. R. Zandomeni
M. Chahdi Beltrame
M. de Santibañes
O. Mazza
J. Pekolj
E. de Santibañes
R. Sanchez Claria
Publication date
01-03-2018
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2018
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9854-0

Other articles of this Issue 1/2018

Journal of Gastrointestinal Cancer 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.